Testosterone therapy and the risk of atrial fibrillation, venous thromboembolism and cardiovascular events in cis men with hypogonadism and trans men
Testosterone treatment in cis men with hypogonadism was associated with a lower risk of myocardial infarction but a higher risk of atrial fibrillation and venous thromboembolism. Testosterone therapy in trans men was not associated with an increased risk of cardiovascular events when compared to untreated trans men or cis men.
Authors
- P.H. Ducluzeau (ORCID: https://orcid.org/0000-0001-6109-0386)
- Patricia Vaduva (ORCID: https://orcid.org/0000-0003-3195-1629)
- Jean -Baptiste De Freminville
- Fabrice Bonnet (ORCID: https://orcid.org/0000-0001-9255-8228)
- Thibaud Genet (ORCID: https://orcid.org/0000-0002-2829-7198)
- Beverley Balkau
- Laurent Fauchier
Institutions
- Université de Tours (FR)
- Inserm (FR)
- Université Paris-Saclay (FR)
- Université Rennes 2 (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Centre Hospitalier Universitaire de Tours (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Physiologie de la Reproduction et des Comportements (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Université de Rennes (FR)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/ejendo/lvaf183
- Citations
- 3
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 3.88